Sandler Capital Management’s Merck MRK Stock Holding History

Sandler Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-27,900	Closed	-$2.94M	–	162
2025 Q4	$2.94M	Buy	+27,900	New	+$2.62M	0.96%	29
2024 Q4	–	Sell	-2,000	Closed	-$227K	–	188
2024 Q3	$227K	Hold	2,000	–	–	0.03%	142
2024 Q2	$248K	Hold	2,000	–	–	0.03%	119
2024 Q1	$264K	Hold	2,000	–	–	0.02%	133
2023 Q4	$218K	Buy	+2,000	New	+$208K	0.02%	105
2019 Q4	–	Sell	-3,563	Closed	-$286K	–	102
2019 Q3	$286K	Hold	3,563	–	–	0.03%	99
2019 Q2	$285K	Sell	3,563 -3,459	-49%	-$265K	0.02%	128
2019 Q1	$557K	Buy	7,022 +524	+8%	+$39.2K	0.04%	104
2018 Q4	$474K	Buy	+6,498	New	+$459K	0.04%	88

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sandler Capital Management's MRK Position: Q1 2026 in Review

Sandler Capital Management sold out of Merck (MRK) in Q1 2026, closing a stake of 27,900 shares — an estimated $2.94M sold.

Sandler Capital Management first reported a position in MRK in Q4 2018 and held it in 9 quarters. The position peaked at $2.94M in Q4 2025. 3,802 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Sandler Capital Management reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
Sandler Capital Management sold 27,900 Merck shares in Q1 2026, an estimated $2.94M.
Sandler Capital Management first reported a position in Merck in Q4 2018 and held it in 9 quarters.
Sandler Capital Management's Merck position peaked at $2.94M in Q4 2025.
3,802 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Sandler Capital Management's 13F filing for Q1 2026, filed 15 May 2026.